Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Annovis Bio, Inc. Common Stock
(NY:
ANVS
)
1.980
-0.050 (-2.46%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Annovis Bio, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Which stocks are experiencing notable movement on Wednesday?
June 04, 2025
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
May 15, 2025
Via
Benzinga
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Advances Phase 3 Alzheimer’s Trial and Expands Conference Presence in Q1
May 14, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results
May 13, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Ongoing Trial Seeks to Avert Alzheimer’s Decades Before it Strikes
February 13, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Appoints Hui Liu as Director of Biostatistics
April 29, 2025
Via
Investor Brand Network
Annovis Bio Appoints Hui Liu as Director of Biostatistics
April 29, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
April 21, 2025
Via
Benzinga
Here are the top movers in Monday's session.
April 21, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
April 21, 2025
Via
Benzinga
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Receives NYSE Noncompliance Notice Over Market Cap and Equity Levels
March 28, 2025
Via
Investor Brand Network
Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE
March 27, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) to Present Late-Stage Alzheimer’s and Parkinson’s Data at AD/PD 2025
March 25, 2025
Via
Investor Brand Network
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program
March 25, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Advances Alzheimer’s and Parkinson’s Pipeline, Launches Pivotal Phase 3 Trial
March 24, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
March 21, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
The Brain’s ‘Cleanup Crew’ Could Hold the Key to Alzheimer’s Treatment, Study Shows
March 14, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) to Present at Alzheimer’s & Parkinson’s Drug Development Summit
March 11, 2025
Via
Investor Brand Network
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
March 11, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Scientists Say Brain Stimulations Hold Potential in Treating Anxiety in Parkinson’s Sufferers
March 04, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) to Host Patient Forum on Alzheimer’s and Parkinson’s Trials
February 19, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) CEO to Present at Oppenheimer Healthcare Conference
February 07, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Enrolls First Patients in Phase 3 Alzheimer’s Trial
February 06, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Closes $21M Public Offering to Advance Alzheimer’s Drug Development
February 05, 2025
Via
Investor Brand Network
Top movers in Monday's session
February 03, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Keep an eye on the top gainers and losers in Monday's session.
February 03, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Traders are paying attention to the gapping stocks in Monday's session.
February 03, 2025
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
BioMedNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Prices $21 Million Public Offering
February 03, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 03, 2025
Via
Benzinga
US Announces Plan to Combat Parkinson’s Disease Across the Country
January 24, 2025
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.